YOLFTbeta
00

Donga Socio Holdings

000640 · KO · Healthcare / Drug Manufacturers - Specialty & Generic

88,200.00KRW-4200.00 (-4.55%)

Price History

Full chart

Market Stats

Previous Close92,400.00
Open92,000.00
Day Range88,000.00 – 94,700.00
52-Week Range73,890.06 – 119,691.40
Volume26.44K
Market Cap606.89B
P/E (TTM)0.00
Forward P/E13.61
Dividend Yield1.85%
Beta0.10
50-Day Avg90,942.00
200-Day Avg95,715.68

About

Dong-A Socio Holdings Co., Ltd., together with its subsidiaries, engages in the pharmaceutical business in South Korea. It operates through Holding Company; Over-the-Counter Drugs and Quai-Drugs; Biosimilars and Consignment Medicines; Logistics; Packaging Solutions; and Others segments. The company develops DA-8010 in Phase 3 clinical trial to treat overactive bladder; DMB-3115, a biosimilar of Stelara in Phase 3 clinical trial; DA-1241 in Phase 2 clinical trial for the treatment of non-alcoholic steatohepatitis; DA-1726 in Phase 1 clinical trial to treat obesity; and STP0404 for the treatment of AIDS. It also provides medical devices and equipment; healthcare solutions to customers in Bacchus, over-the-counter, consumer healthcare, and cosmetics; health functional food; contract development and manufacturing organization for biosimilar and pharmaceutical products, and oligonucleotide therapeutics; functional sports drinks under the POCARI SWEAT brand; logistics and fulfillment services; glass bottles, PET bottles, aluminum and plastic caps, and paper packaging boxes; mineral and carbonated water, and mixed drinks; and IT and construction services. In addition, the company is involved in engineering; cargo, courier, and automobile transport arrangement; transportation warehousing and leasing; real estate development; agricultural product distribution; management consulting; business management; and architectural, electric work, fire protection, and housing contracting services. Dong-A Socio Holdings Co., Ltd. was founded in 1932 and is headquartered in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Min-Young Kim
  • Employees79
  • Headquarters64, Cheonho-daero, Seoul, South Korea, 02587, Korea
  • Websitehttps://www.donga.co.kr

Leadership

  • Mr. Min-Young KimCEO, President & Executive Director · b. 1972
  • Mr. Seung Hyun KoExecutive Director, CFO & Head of Management Support Office · b. 1976
  • Seong-Yeon JeongCompliance Officer · b. 1982
  • Mr. Dae-Woo LeeExecutive Director & Head of Management Planning · b. 1973

Financials

Income Statement

Currency: KRW2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue467.84B559.33B618.32B723.32B786.50B743.45B764.41B686.81B763.59B866.23B947.64B1.06T1.11T570.87B630.63B704.73B726.17B690.26B707.17B769.35B783.32B881.94B1.01T1.13T1.33T1.43T
Growth (%)-+19.56%+10.55%+16.98%+8.74%-5.47%+2.82%-10.15%+11.18%+13.44%+9.40%+11.40%+4.76%-48.38%+10.47%+11.75%+3.04%-4.94%+2.45%+8.79%+1.82%+12.59%+15.07%+11.54%+17.78%+7.24%
Cost of Revenue259.01B313.69B333.01B408.79B432.06B351.04B345.57B294.83B312.69B369.33B398.25B504.37B575.05B366.44B419.81B439.93B442.85B444.50B471.81B504.73B521.33B600.46B720.48B757.13B925.16B973.12B
Gross Profit-------------181.98B189.28B264.81B283.31B245.77B235.36B264.62B261.98B281.48B294.39B374.87B408.07B456.65B
Gross Margin-------------31.88%30.01%37.58%39.02%35.60%33.28%34.39%33.45%31.92%29.01%33.12%30.61%31.94%
Operating Expense-------------148.34B168.45B200.45B207.32B192.39B185.14B212.13B211.38B219.92B256.53B297.99B325.97B358.88B
Operating Income57.22B37.63B69.84B50.02B59.98B48.09B61.89B75.78B84.03B101.44B126.86B115.35B105.84B33.64B20.83B64.36B76.00B53.37B50.22B52.49B50.61B61.56B37.85B76.88B82.09B97.77B
Operating Margin12.23%6.73%11.29%6.92%7.63%6.47%8.10%11.03%11.00%11.71%13.39%10.93%9.57%5.89%3.30%9.13%10.47%7.73%7.10%6.82%6.46%6.98%3.73%6.79%6.16%6.84%
EBITDA-----------------82.30B-137.02B97.67B235.44B136.98B103.20B162.65B194.87B178.09B
EBITDA Margin-----------------11.92%-19.38%12.70%30.06%15.53%10.17%14.37%14.62%12.46%
Net Income21.63B23.72B45.32B19.95B26.69B25.44B-34.76B43.38B63.26B73.59B69.22B85.88B15.57B1.72B47.88B149.05B32.54B-163.98B19.76B162.35B60.27B11.15B57.99B58.02B90.94B
Net Income Margin4.62%4.24%7.33%2.76%3.39%3.42%-5.06%5.68%7.30%7.77%6.56%7.76%2.73%0.27%6.79%20.53%4.71%-23.19%2.57%20.73%6.83%1.10%5.12%4.35%6.36%
R&D-----------76.82B-32.14B34.91B37.22B28.67B17.59B22.18B21.46B18.85B6.52B6.42B7.39B8.87B9.49B
R&D as % of Total Revenue-----------7.28%-5.63%5.54%5.28%3.95%2.55%3.14%2.79%2.41%0.74%0.63%0.65%0.67%0.66%
Interest Expense00000000000000000011.96B13.42B11.98B11.50B14.85B22.75B29.29B28.65B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%1.69%1.74%1.53%1.30%1.46%2.01%2.20%2.00%

Balance Sheet

Currency: KRW2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets547.36B593.63B590.72B691.41B706.01B724.29B731.74B713.72B769.94B1.06T1.23T1.49T1.72T988.28B1.08T1.22T1.40T1.46T1.24T1.36T1.51T1.69T1.73T1.96T2.03T2.08T
Total Liabilities339.30B402.76B371.20B424.69B399.17B380.07B412.19B385.03B419.00B476.92B488.66B630.85B841.87B473.68B546.59B620.88B526.36B545.20B506.17B611.67B622.38B706.35B732.79B929.80B966.55B927.77B
Total Equity193.14B186.98B218.88B221.51B262.75B301.11B280.26B327.95B350.21B580.07B728.86B825.37B848.85B471.59B485.73B521.60B875.86B912.75B734.19B745.14B888.71B965.16B981.99B1.01T1.05T1.14T
Cash18.29B36.50B36.91B41.85B41.27B46.58B50.70B56.90B44.89B50.58B150.50B177.33B381.21B198.18B134.82B119.99B95.94B179.49B107.49B86.82B88.77B99.63B95.13B119.86B117.39B122.56B
Net Debt-----------------219.02B263.38B318.77B332.27B383.79B404.39B467.76B508.91B435.54B

Cash Flow

Currency: KRW2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow44.43B58.75B48.24B47.29B47.62B35.86B83.27B44.50B63.53B96.72B144.60B121.50B55.72B35.78B-7.92B80.94B30.48B84.46B58.32B96.79B84.57B131.09B75.87B158.70B82.99B227.39B
Investing Cash Flow--------------138.53B-116.50B-106.92B-66.93B-26.33B-75.07B-116.11B-47.97B-136.61B----
Financing Cash Flow---15.98B-3.97B-49.15B6.19B3.70B63.89B35.23B168.00B-80.19B61.14B11.10B12.48B27.30B-56.07B-1.68B-34.42B16.03B----
Capital Expenditure20.60B22.43B28.09B28.62B28.45B36.24B47.51B79.83B73.41B71.92B111.08B92.86B72.06B109.71B87.10B96.88B64.98B24.99B25.12B44.94B51.93B70.06B78.60B159.52B75.57B58.62B
Free Cash Flow-----------------55.06B26.25B51.63B29.36B52.36B-2.73B-825.27M7.43B168.77B
Dividends Paid4.84B4.02B4.71B9.24B6.48B7.14B5.45B6.80B7.54B7.66B8.15B11.00B11.56B10.68B5.33B5.35B6.99B6.05B6.14B6.14B6.14B9.18B9.38B12.50B11.88B10.76B
FCF to OCF-----------------65.19%45.01%53.35%34.72%39.94%-3.59%-0.52%8.95%74.22%
Dividend Paid to FCF-----------------10.99%23.38%11.89%20.91%17.54%-343.91%-1514.84%159.92%6.37%

Earnings

Report DateMay 4, 2005Aug 12, 2005Nov 10, 2005Feb 3, 2006Apr 27, 2006Jul 25, 2006Oct 30, 2006Feb 2, 2007Apr 30, 2007Jul 26, 2007Oct 21, 2007Jan 30, 2008Apr 24, 2008Jul 24, 2008Mar 29, 2009Oct 20, 2009Jan 26, 2010May 13, 2010Aug 12, 2010Nov 12, 2010Mar 30, 2011May 9, 2011Jul 28, 2011Nov 14, 2011Feb 6, 2012May 13, 2013Aug 2, 2013Oct 28, 2013Feb 3, 2014May 12, 2014Aug 29, 2014Nov 28, 2014Feb 17, 2015May 15, 2015Aug 16, 2015Nov 16, 2015Feb 18, 2016May 13, 2016Aug 12, 2016Nov 14, 2016Jan 20, 2017May 15, 2017Aug 14, 2017Nov 14, 2017Feb 26, 2018May 14, 2018Aug 14, 2018Oct 29, 2018Dec 31, 2018May 15, 2019Aug 13, 2019Nov 14, 2019Feb 24, 2020May 15, 2020Aug 14, 2020Nov 16, 2020Feb 17, 2021May 17, 2021Aug 17, 2021Nov 15, 2021Feb 23, 2022May 4, 2022Aug 9, 2022Nov 2, 2022Feb 16, 2023May 7, 2023Jul 27, 2023Oct 30, 2023Mar 28, 2024May 1, 2024Aug 14, 2024Nov 1, 2024Apr 29, 2025Jul 23, 2025Oct 30, 2025Dec 31, 2025Apr 27, 2026Jun 30, 2026
EPS Estimate1446.631113.142866.1115832.391890.314270.033163.615738.022519.022886.914399.405684.561571.782922.693768.373730.174377.163397.374093.293600.674058.37-5379.934725.56--------------1834.00630.00436.00----436.00---------2210.241166.541282.011431.512505.722526.58478.93-2526.58-2526.582526.582526.581716.932308.932378.272883.16------
EPS Actual1253.652628.772006.79635.731292.582723.572575.781840.06-7829.241259.093696.883536.511308.192711.572377.443771.555332.443714.948214.502361.512663.684757.105379.934979.491517.04-5718.67260.281851.66-573.24-103.46571.04392.40-636.42-220.3010975.10-217.56-447.151687.7522593.002374.001535.00-184.733449.602154.15-640.40-319.833685.88476.18-30.00-93.10891.712682.15-445.731370.001066.672100.0022212.00131.002598.0010198.00-2956.27-617.001480.004086.00-3175.30-2956.27-2956.27-2956.27368.001255.002763.004426.00814.165835.087301.15-1730.693082.004324.00
Surprise-13.34%136.16%-29.98%-95.98%-31.62%-36.22%-18.58%-67.93%-410.81%-56.39%-15.97%-37.79%-16.77%-7.22%-36.91%1.11%21.82%9.35%100.68%-34.41%-34.37%-0.00%5.37%--------------1131.90%276.83%252.06%-----173.36%----------4.99%1804.09%-89.78%81.49%306.99%-217.01%-228.83%-61.72%--217.01%-217.01%-217.01%-78.57%-45.65%16.18%53.51%------
TimingPre-market-After-hoursPre-marketAfter-hoursPre-market-Pre-marketPre-marketAfter-hoursAfter-hoursAfter-hours--After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hours------Pre-marketPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-market----------Pre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-market-Pre-market-

Key Statistics & Ratios

Market Cap606.89B
Enterprise Value1.08T
Trailing P/E0.00
Forward P/E13.61
PEG Ratio0.00
Price / Sales0.40
Price / Book0.52
Revenue (TTM)1.52T
Gross Profit (TTM)483.03B
EBITDA205.81B
Profit Margin5.62%
Operating Margin9.45%
Return on Equity7.32%
Return on Assets3.15%
Shares Outstanding6.44M
Shares Float3.07M
Beta0.10
Dividend Yield1.85%
Dividend Rate1,700.00
Payout Ratio13.10%

Dividends

20262×
700.00Jul 30, 20261000.00Mar 11, 2026
20252×
679.61Jul 30, 2025970.87Mar 13, 2025
20241×
659.82Jun 27, 2024
20232×
1131.12Dec 27, 2023942.60Jun 29, 2023
20223×
942.60Dec 28, 2022500.00Sep 29, 2022471.30Jun 29, 2022
20212×
942.60Dec 29, 2021471.30Sep 29, 2021
20201×
942.60Dec 29, 2020
20191×
942.60Dec 27, 2019
20181×
942.60Dec 27, 2018
20171×
942.60Dec 27, 2017
20161×
942.60Dec 28, 2016
20151×
942.60Dec 29, 2015
20141×
942.60Dec 29, 2014
20131×
942.60Dec 27, 2013
20121×
2539.26Dec 27, 2012
20111×
2539.26Dec 28, 2011
20101×
2539.26Dec 29, 2010
20091×
273.59Dec 29, 2009

Stock Splits

  • Mar 11, 20261.03:1
  • Mar 13, 20251.03:1
  • Apr 8, 20130.3712:1
  • Dec 29, 20091.0201:1
  • Dec 29, 20081.0201:1
  • Dec 27, 20071.02:1
  • Dec 27, 20061.02:1
  • Dec 28, 20051.02:1